Annual FCF
-$163.40 M
-$47.99 M-41.58%
December 31, 2023
Summary
- As of February 7, 2025, NMRA annual free cash flow is -$163.40 million, with the most recent change of -$47.99 million (-41.58%) on December 31, 2023.
- During the last 3 years, NMRA annual FCF has fallen by -$135.34 million (-482.31%).
- NMRA annual FCF is now -482.31% below its all-time high of -$28.06 million, reached on December 1, 2020.
Performance
NMRA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$33.48 M
+$22.68 M+40.38%
September 30, 2024
Summary
- As of February 7, 2025, NMRA quarterly free cash flow is -$33.48 million, with the most recent change of +$22.68 million (+40.38%) on September 30, 2024.
- Over the past year, NMRA quarterly FCF has increased by +$9.47 million (+22.05%).
- NMRA quarterly FCF is now -144.29% below its all-time high of -$13.71 million, reached on June 1, 2021.
Performance
NMRA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$184.08 M
+$14.33 M+7.22%
September 30, 2024
Summary
- As of February 7, 2025, NMRA TTM free cash flow is -$184.08 million, with the most recent change of +$14.33 million (+7.22%) on September 30, 2024.
- Over the past year, NMRA TTM FCF has dropped by -$10.81 million (-6.24%).
- NMRA TTM FCF is now -1086.32% below its all-time high of -$15.52 million, reached on March 1, 2021.
Performance
NMRA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
NMRA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -41.6% | +22.1% | -6.2% |
| 3 y3 years | -482.3% | -25.1% | -73.4% |
| 5 y5 years | - | -25.1% | -73.4% |
NMRA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -114.3% | at low | -29.3% | +40.4% | -141.5% | +7.2% |
| 5 y | 5-year | -482.3% | at low | -144.3% | +40.4% | -1086.3% | +7.2% |
| alltime | all time | -482.3% | at low | -144.3% | +40.4% | -1086.3% | +7.2% |
Neumora Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$33.48 M(-40.4%) | -$184.08 M(-7.2%) |
| Jun 2024 | - | -$56.16 M(+30.7%) | -$198.41 M(+14.5%) |
| Mar 2024 | - | -$42.95 M(-16.6%) | -$173.27 M(+6.0%) |
| Dec 2023 | -$163.40 M(+41.6%) | -$51.49 M(+7.7%) | -$163.40 M(+14.8%) |
| Sep 2023 | - | -$47.81 M(+54.1%) | -$142.30 M(+18.2%) |
| Jun 2023 | - | -$31.02 M(-6.2%) | -$120.38 M(+3.7%) |
| Mar 2023 | - | -$33.08 M(+8.8%) | -$116.12 M(+0.6%) |
| Dec 2022 | -$115.41 M | -$30.39 M(+17.4%) | -$115.41 M(+0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$25.89 M(-3.2%) | -$114.56 M(+7.9%) |
| Jun 2022 | - | -$26.76 M(-17.3%) | -$106.14 M(+14.0%) |
| Mar 2022 | - | -$32.36 M(+9.6%) | -$93.08 M(+22.1%) |
| Dec 2021 | -$76.24 M(+171.7%) | - | - |
| Dec 2021 | - | -$29.54 M(+69.1%) | -$76.24 M(+63.3%) |
| Sep 2021 | - | -$17.47 M(+27.5%) | -$46.70 M(+59.8%) |
| Jun 2021 | - | -$13.71 M(-11.7%) | -$29.22 M(+88.3%) |
| Mar 2021 | - | -$15.52 M | -$15.52 M |
| Dec 2020 | -$28.06 M | - | - |
FAQ
- What is Neumora Therapeutics annual free cash flow?
- What is the all time high annual FCF for Neumora Therapeutics?
- What is Neumora Therapeutics annual FCF year-on-year change?
- What is Neumora Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly FCF year-on-year change?
- What is Neumora Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Neumora Therapeutics?
- What is Neumora Therapeutics TTM FCF year-on-year change?
What is Neumora Therapeutics annual free cash flow?
The current annual FCF of NMRA is -$163.40 M
What is the all time high annual FCF for Neumora Therapeutics?
Neumora Therapeutics all-time high annual free cash flow is -$28.06 M
What is Neumora Therapeutics annual FCF year-on-year change?
Over the past year, NMRA annual free cash flow has changed by -$47.99 M (-41.58%)
What is Neumora Therapeutics quarterly free cash flow?
The current quarterly FCF of NMRA is -$33.48 M
What is the all time high quarterly FCF for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly free cash flow is -$13.71 M
What is Neumora Therapeutics quarterly FCF year-on-year change?
Over the past year, NMRA quarterly free cash flow has changed by +$9.47 M (+22.05%)
What is Neumora Therapeutics TTM free cash flow?
The current TTM FCF of NMRA is -$184.08 M
What is the all time high TTM FCF for Neumora Therapeutics?
Neumora Therapeutics all-time high TTM free cash flow is -$15.52 M
What is Neumora Therapeutics TTM FCF year-on-year change?
Over the past year, NMRA TTM free cash flow has changed by -$10.81 M (-6.24%)